よむ、つかう、まなぶ。
参考資料14 高齢者がん医療Ｑ＆Ａ総論（厚生労働科学研究「高齢者がん診療指針策定に必要な基盤整備に関する研究」） (4 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_28073.html |
| 出典情報 | がん対策推進協議会（第82回 9／20）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
11. 皮膚障害
Q1
高齢者の皮膚は非高齢者と異なるか？ ················································································ 116
Q2
高齢者のがん治療に際し、皮膚のケアで気をつけるところは何か？ ········································· 117
12. リンパ浮腫
Q1
がんの治療によって誘発された上肢や下肢のリンパ浮腫に対して、高齢者には特別な留意点が
あるか？ ························································································································ 119
13. 輸血
Q1
高齢者においては輸血の適応に違いがあるか？ ···································································· 121
Q2
高齢者において注意が必要な輸血副反応は何か？ ································································· 122
Q3
高齢者の輸液で気をつける点は何か？ ················································································ 123
第4章
外科系治療総論 ······························································································124
麻酔総論
高齢者がんの麻酔で留意すべきことは何か？ ·································································· 124
Q1-1
外科治療において高齢者癌手術の現状はどうか？ ································································· 128
Q1-2
根治手術が可能な高齢がん患者の選択の基準はあるか？ ························································ 129
Q2
手術の諾否は高齢であっても患者自身がすべきか？ ······························································ 130
Q3
手術合併症を予測する因子は何か？ ··················································································· 131
Q4
年齢により手術成績は異なるか？ ······················································································ 132
第5章
放射線治療総論 ······························································································133
Q1
放射線療法は何歳まで可能か？ ························································································· 133
Q2
標準的な照射ができる条件は何か？ ··················································································· 135
Q3
高齢者における放射線療法の急性期有害事象は、非高齢者と異なるか？ ··································· 137
急性期有害事象の発生頻度や重症度は、非高齢者に比べて増加するか？
Q4
高齢者では放射線療法の効果が異なることはあるのか？ ························································ 139
Q5
高齢者では、非高齢者と比較して放射線治療後の晩期有害事象の頻度や重症度は増加するか？ ····· 141
第6章
低侵襲治療（IVR と内視鏡治療）総論 ·································································143
1.IVR 治療
Q1
高齢者に可能な IVR や内視鏡治療にはどのようなものがあるか？ ··········································· 143
Q2
高齢者における生検の IVR /内視鏡の適応/条件は何か？ ························································ 146
2.内視鏡治療
Q1
内視鏡治療に年齢制限はあるか？ ······················································································ 147
Q2
高齢者の早期消化管癌に対する内視鏡治療の適応・条件は何か? ·············································· 151
Q3
高齢者における内視鏡治療でとくに注意すべきことは何か？ ·················································· 154
第7章
精神科的治療 ································································································· 157
Q1
高齢者のせん妄に対して、がん治療医が注意すべき点は何か？ ··············································· 157
Q2
認知症をもつがん患者の治療適応をどのように考えるか？ ····················································· 160
Q3
高齢者の意思決定能力の評価はどのようにするか？ ······························································ 161
Q4
認知症のあるがん患者の治療を進める上で、がん治療医が注意すべき点は何か？ ······················· 163
Q5
高齢がん患者において、抑うつの評価と治療はなぜ重要か？ ·················································· 165
Q6
高齢がん患者の抑うつはどう評価すべきか？ ······································································· 168
Q1
高齢者の皮膚は非高齢者と異なるか？ ················································································ 116
Q2
高齢者のがん治療に際し、皮膚のケアで気をつけるところは何か？ ········································· 117
12. リンパ浮腫
Q1
がんの治療によって誘発された上肢や下肢のリンパ浮腫に対して、高齢者には特別な留意点が
あるか？ ························································································································ 119
13. 輸血
Q1
高齢者においては輸血の適応に違いがあるか？ ···································································· 121
Q2
高齢者において注意が必要な輸血副反応は何か？ ································································· 122
Q3
高齢者の輸液で気をつける点は何か？ ················································································ 123
第4章
外科系治療総論 ······························································································124
麻酔総論
高齢者がんの麻酔で留意すべきことは何か？ ·································································· 124
Q1-1
外科治療において高齢者癌手術の現状はどうか？ ································································· 128
Q1-2
根治手術が可能な高齢がん患者の選択の基準はあるか？ ························································ 129
Q2
手術の諾否は高齢であっても患者自身がすべきか？ ······························································ 130
Q3
手術合併症を予測する因子は何か？ ··················································································· 131
Q4
年齢により手術成績は異なるか？ ······················································································ 132
第5章
放射線治療総論 ······························································································133
Q1
放射線療法は何歳まで可能か？ ························································································· 133
Q2
標準的な照射ができる条件は何か？ ··················································································· 135
Q3
高齢者における放射線療法の急性期有害事象は、非高齢者と異なるか？ ··································· 137
急性期有害事象の発生頻度や重症度は、非高齢者に比べて増加するか？
Q4
高齢者では放射線療法の効果が異なることはあるのか？ ························································ 139
Q5
高齢者では、非高齢者と比較して放射線治療後の晩期有害事象の頻度や重症度は増加するか？ ····· 141
第6章
低侵襲治療（IVR と内視鏡治療）総論 ·································································143
1.IVR 治療
Q1
高齢者に可能な IVR や内視鏡治療にはどのようなものがあるか？ ··········································· 143
Q2
高齢者における生検の IVR /内視鏡の適応/条件は何か？ ························································ 146
2.内視鏡治療
Q1
内視鏡治療に年齢制限はあるか？ ······················································································ 147
Q2
高齢者の早期消化管癌に対する内視鏡治療の適応・条件は何か? ·············································· 151
Q3
高齢者における内視鏡治療でとくに注意すべきことは何か？ ·················································· 154
第7章
精神科的治療 ································································································· 157
Q1
高齢者のせん妄に対して、がん治療医が注意すべき点は何か？ ··············································· 157
Q2
認知症をもつがん患者の治療適応をどのように考えるか？ ····················································· 160
Q3
高齢者の意思決定能力の評価はどのようにするか？ ······························································ 161
Q4
認知症のあるがん患者の治療を進める上で、がん治療医が注意すべき点は何か？ ······················· 163
Q5
高齢がん患者において、抑うつの評価と治療はなぜ重要か？ ·················································· 165
Q6
高齢がん患者の抑うつはどう評価すべきか？ ······································································· 168